BACKGROUND: Medication-assisted treatment with @entity4783 or @entity284 is recommended for pregnant @entity1 with @entity4784 to minimize adverse maternal and neonatal outcomes. Collaborative care approaches have been successfully utilized with office-based opioid treatment with @entity4783 in primary care settings, but research is significantly limited in the obstetric setting. Our aim with this study is to demonstrate the feasibility of a collaborative care model for pregnant @entity1 with @entity4784 . METHODS: This is a case series of 16 pregnancies in 14 @entity1 initiated on office-based opioid treatment with @entity4783 in a perinatal mental health service embedded in two obstetric clinics. @entity1 are treated by a psychiatrist alongside their prenatal care provider and followed for up to 6  months postpartum and referred to ongoing substance abuse treatment to a community prescriber. RESULTS: The average age of the @entity1 was 30.3  years and an average gestational age of 23.6  weeks at the time of referral. Treatment continued until delivery in 15 (93.8%) pregnancies, with an average duration of treatment of 14.5  weeks. The majority (60%) had a cesarean delivery. Twelve (80%) @entity1 were admitted to the Neonatal Intensive Care Unit (NICU) for monitoring or treatment of @entity6767 , Fourteen (87.5%) @entity1 continued or resumed treatment with @entity4783 postpartum at the time of discharge from our program and 13 (81.3%) were referred to a community prescriber. CONCLUSIONS: A collaborative care approach to @entity4783 treatment is feasible during pregnancy. Further research is needed to improve the treatment of OUD during pregnancy.

Feasibility of collaborative care treatment of XXXX with @entity4783 during pregnancy.

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients', 'infants'] @entity6767 :: ('MESH:D009357', 'Disease') :: ['Neonatal Abstinence Syndrome'] @entity4784 :: ('MESH:D009293', 'Disease') :: ['opioid use disorder', 'opioid use disorders'] @entity4783 :: ('MESH:D002047', 'Chemical') :: ['buprenorphine'] @entity284 :: ('MESH:D008691', 'Chemical') :: ['methadone']
@entity4784 :: (MESH:D009293,Disease) :: ['opioid use disorders']
